Travere Therapeutics Inc — キャッシュフロー (NASDAQ:TVTX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -42.74 M-14.79 M-186.29 M-280.02 M-237.47 M37.78 M 37.78 M 投資活動によるキャッシュフロー -61.33 M-137.62 M-32.55 M55.78 M99.33 M27.89 M 27.89 M 財務活動によるキャッシュフロー 127.71 M231.68 M117.57 M218.75 M139.42 M-33.47 M -33.47 M フリーキャッシュフロー -67.31 M-38.94 M-214.85 M-322.28 M-273.69 M-20.37 M -20.51 M

ニュース

Travere Therapeutics: Re-Rating Potential As Filspari Wins Full Approval (NASDAQ:TVTX)

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock?

Stocks Rally on a Push for Diplomacy to End US-Iran War

Stocks Rally on US-Iran Peace Hopes and Cooler PPI Growth

Stocks Climb on US-Iran Peace Talk Optimism and a Favorable PPI Report

Travere Therapeutics Stock Skyrockets On Highly Anticipated FDA Approval

Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS Transcript

Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS - Slideshow (NASDAQ:TVTX) 2026-04-13

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

ASML, An AI Megatrend Star, Leads 8 Newcomers To Best Stock Lists

Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show Resilience